Tuesday, January 10, 2012

Pfizer (PFE) (MMI) (PRX) (ANGO) (APH) (ART) Ratings Reiterated

Pfizer Inc. (NYSE: PFE), Motorola Mobility (NYSE: MMI), Par Pharmaceutical Companies Incorporated (NYSE: PRX), AngioDynamics (NASDAQ: ANGO), Amphenol Co. (NYSE: APH) and Artio Global Investors Inc. (NYSE: ART) had ratings on them reiterated by analysts.

Goldman Sachs (NYSE:GS) reiterated its "Conviction Buy" rating on Pfizer Inc. (PFE).

Canaccord Genuity reiterated its "Hold" rating on Motorola Mobility (MMI).

UBS AG (NYSE:UBS) reiterated its "Buy" rating on Par Pharmaceutical Companies Incorporated (PRX).

Zacks Investment Research reiterated its "Neutral" rating on AngioDynamics (ANGO). They have a price target of $14.00 on the company.

Goldman Sachs reiterated its "Neutral" rating on Amphenol Co. (APH).

Goldman Sachs reiterated its "Neutral" rating on Artio Global Investors Inc. (ART).

No comments:

Post a Comment